Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Apollo Hospitals share price turns negative after hitting record high of ₹8,948.10 apiece on BSE. Do you own? - livemint.com
Apollo Hospitals share price turns negative after hitting record high of ₹8,948.10 apiece on BSE. Do you own?livemint.com
Supriya Lifescience Ltd leads losers in 'A' group
PC Jeweller Ltd, Zensar Technologies Ltd, Ola Electric Mobility Ltd and Apollo Micro Systems Ltd are among the other losers in the BSE's 'A' group today, 06 July 2026.
Apollo Hospitals among 8 largecap stocks hit 52-week highs, rally up to 12% in a month
Indian markets remained firm with Sensex closing higher, supporting momentum in largecap stocks. Eight companies, including Apollo Hospitals and Bosch, hit 52-week highs amid sustained buying interest. Gains of up to 12% in a month highlight strong investor confidence and continued bullish sentiment in select sectors.
Zydus partners with Guardant Health and Apollo Hospitals to introduce Shield MCD in India
Zydus Lifesciences and Guardant Health, Inc., a leading precision oncology company, have an exclusive agreement to make the Shield Multi-Cancer Detection (MCD) test available in India, for which Zydus has signed a Memorandum of Understanding (MoU) with Apollo Hospitals to offer the test in the territory.
Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection test
Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through an agreement with Guardant Health. This innovative blood test can identify signals for multiple cancer types in individuals aged 45 and above. The collaboration aims to enhance early cancer detection and improve patient outcomes across the nation, making advanced screening more accessible.
Zydus Lifesciences, Apollo Hospitals partner to expand access to multi-cancer blood test in India
Zydus Lifesciences and Apollo Hospitals partner to expand access to Shield Multi-Cancer Detection blood test in India, screening 10 common cancers.
Rajesh Palviya of Axis Sec suggests Five-Star Business, Apollo Tyres, Exide Industries shares to buy today
Sensex and Nifty 50 surged on Friday, driven by IT stocks amid optimism from softer US jobs data. Nifty 50 rose 0.83% to 24,375.65, with 15 of 16 sectoral indices in the green, reflecting positive market sentiment despite ongoing global uncertainties.
Stocks to Watch for June 18: Lupin, HFCL, RVNL, Apollo Hospitals and more
Lupin, HFCL and RVNL have announced key business wins, while Bosch Global Software Technologies plans an OFS in Bosch Home Comfort India. Apollo Hospitals has also settled an RBI compounding case with a ₹17.8 crore payment. Here are stocks to watch ahead of Thursday’s session.
RBI Compounds FEMA Violations In Apollo Hospitals Case After Rs 18.6-Crore Payment
Apollo Hospitals pays Rs 17.77 crore, while five directors/officers pay Rs 18 lakh each after RBI compounds FEMA contraventions following ED's no-objection.
Apollo Hospitals, directors get relief as RBI compounds FEMA violations
Apollo Hospitals resolved a FEMA violation case with a ₹17.8 crore settlement after RBI issued a compounding order, resulting in the closure of adjudication proceedings against the company and its directors.
FEMA probe against Apollo Hospitals, 5 directors closed after compounding order: ED
A foreign exchange violation case against Apollo Hospitals and five directors has been terminated. The Reserve Bank of India issued a compounding order. Apollo Hospitals Enterprises Limited made a one-time payment of over Rs 17.76 crore. The executives also paid Rs 18 lakh each. This settlement resolves alleged contraventions totalling more than Rs 2,424 crore.
Apollo Hospitals taps Shobana Kamineni to chair soon-to-be listed Healthtech unit
Apollo Hospitals is appointing Shobana Kamineni as executive chairperson of its upcoming medical equipment business, Apollo Healthtech. This move is part of a larger restructuring plan to unlock business value. Apollo Healthtech is expected to be listed separately. The company aims for significant revenue by listing. This signals a focus on growth and governance for the new entity.